A quick and simple validated method for the quantitative analysis of ibrutinib and its dihydrodiol metabolite was designed.
Ibrutinib exhibits instability in human plasma, where the acryl moiety is lost.
In FVB mice, ibrutinib is rapidly eliminated and converted into dihydrodiol-ibrutinib.